Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India.
Metrics to compare | BLUJ | Peers Peers - average of corresponding metrics from companies closely matching BLUJ: ACCENTMIC, GLAND, JSLL, NATCOPHARM, ALKEM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLUJPeersSector |
---|---|---|---|---|
P/E Ratio | 58.8x | 42.2x | −0.6x | |
PEG Ratio | −5.46 | 0.17 | 0.00 | |
Price/Book | 11.0x | 5.0x | 2.6x | |
Price / LTM Sales | 13.3x | 5.2x | 3.1x | |
Upside (Analyst Target) | 2.4% | −0.3% | 56.8% | |
Fair Value Upside | Unlock | −14.5% | 7.7% | Unlock |